chr1-24929745-C-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004350.3(RUNX3):c.124G>T(p.Val42Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000211 in 1,472,144 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004350.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RUNX3 | NM_004350.3 | c.124G>T | p.Val42Leu | missense_variant | 1/5 | ENST00000308873.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RUNX3 | ENST00000308873.11 | c.124G>T | p.Val42Leu | missense_variant | 1/5 | 1 | NM_004350.3 | ||
RUNX3 | ENST00000338888.4 | c.166G>T | p.Val56Leu | missense_variant | 3/7 | 1 | P1 | ||
RUNX3 | ENST00000479341.1 | n.276G>T | non_coding_transcript_exon_variant | 3/3 | 1 | ||||
RUNX3 | ENST00000399916.5 | c.166G>T | p.Val56Leu | missense_variant | 2/6 | 2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152130Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.0000197 AC: 26AN: 1320014Hom.: 0 Cov.: 30 AF XY: 0.0000169 AC XY: 11AN XY: 651158
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152130Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74312
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2024 | The c.166G>T (p.V56L) alteration is located in exon 2 (coding exon 2) of the RUNX3 gene. This alteration results from a G to T substitution at nucleotide position 166, causing the valine (V) at amino acid position 56 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at